CoreCap Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.96K Sell
15
-8
-35% -$1.2K ﹤0.01% 2505
2026
Q2
$3.5K Buy
23
+14
+156% +$2.33K ﹤0.01% 2379
2026
Q1
$1.89K Sell
9
-1
-10% -$251 ﹤0.01% 2423
2025
Q4
$2.84K Buy
10
+2
+25% +$625 ﹤0.01% 2379
2025
Q3
$2.47K Sell
8
-6
-43% -$1.88K ﹤0.01% 2338
2025
Q2
$4.4K Buy
14
+2
+17% +$577 ﹤0.01% 2147
2025
Q1
$3.15K Hold
12
– – ﹤0.01% 2224
2024
Q4
$3.13K Buy
12
+8
+200% +$2.02K ﹤0.01% 2102
2024
Q3
$931 Hold
4
– – ﹤0.01% 2281
2024
Q2
$807 Hold
4
– – ﹤0.01% 1408
2024
Q1
$686 Buy
+4
New +$746 ﹤0.01% 2287

Other funds holding PODD

CoreCap Advisors's PODD Position: Q3 2026 in Review

CoreCap Advisors reduced its Insulet (PODD) stake by 35% in Q3 2026, selling an estimated $1.2K and leaving 15 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

CoreCap Advisors first reported a position in PODD in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.4K in Q2 2025. 118 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • CoreCap Advisors held 15 shares of Insulet worth $1.96K as of Q3 2026.
  • CoreCap Advisors sold 8 Insulet shares in Q3 2026, an estimated $1.2K.
  • Insulet made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2505 holding.
  • CoreCap Advisors first reported a position in Insulet in Q1 2024 and has held it in 11 quarters since.
  • CoreCap Advisors's Insulet position peaked at $4.4K in Q2 2025.
  • 118 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.